Kamran Hosseini | Biochemistry | Best Researcher Award

Published on by Academic Achievements

Best Researcher Award

Kamran Hosseini
Affiliation Shiraz University of Medical Sciences
Country Iran
Scopus ID 57226155096
Documents 32
Citations 638
h-index 10
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards
ORCID 0000-0003-1189-7143

Kamran Hosseini
Shiraz University of Medical Sciences, Iran

The Best Researcher Award recognizes distinguished scholars whose sustained scientific achievements, publication record, research quality, and academic influence demonstrate excellence within their respective disciplines. Kamran Hosseini has established an active research profile in biochemistry, genetics, molecular biology, neuroscience, and clinical medicine through peer-reviewed publications addressing neurological disorders, molecular signaling pathways, spinal surgery, and translational biomedical research.[1] His scholarly output, citation impact, and international visibility provide evidence of continued contributions to medical science and interdisciplinary biomedical research.[2]

Abstract

Kamran Hosseini has contributed to contemporary biomedical research through investigations spanning molecular biology, neurology, neurosurgery, gene therapy, spinal disorders, and translational medicine. His publication portfolio demonstrates interdisciplinary collaboration while integrating laboratory discoveries with clinical applications. Current research includes viral vector-mediated therapeutic strategies, spinal surgery outcomes, neurological disease mechanisms, and complex neurosurgical case management.[3] Such work reflects sustained engagement with evidence-based medicine and translational biomedical science.

Keywords

Best Researcher Award, Kamran Hosseini, Neuroscience, Molecular Biology, Gene Therapy, AAV Vectors, Biochemistry, Genetics, Neurosurgery, Clinical Research, Biomedical Science, Translational Medicine, Shiraz University of Medical Sciences.

Introduction

Recognition through a Best Researcher Award is commonly based upon sustained scholarly productivity, measurable research impact, publication quality, interdisciplinary collaboration, and contributions to scientific advancement. Researchers working across molecular biology and clinical medicine play an important role in translating laboratory discoveries into practical healthcare improvements.[1] Kamran Hosseini’s research activities illustrate this translational approach by integrating basic biological science with clinical neurosurgical investigations.

Research Profile

  • Affiliation: Shiraz University of Medical Sciences
  • Primary discipline: Biochemistry, Genetics and Molecular Biology
  • Scopus documents: 32
  • Total citations: 638
  • Scopus h-index: 10
  • Research interests include neuroscience, molecular signaling pathways, neurosurgery, spinal disorders, translational medicine, and gene therapy.

Research Contributions

The research portfolio demonstrates contributions across molecular neuroscience, neurological disorders, spinal surgery, and clinical case studies. Recent investigations evaluate adeno-associated virus (AAV) vectors for therapeutic modulation of cellular signaling pathways, assess perioperative interventions to reduce blood loss during spinal fusion procedures, and document rare neurosurgical cases that contribute to evidence-based clinical decision making.[3] These publications illustrate interdisciplinary collaboration between molecular biology and clinical neuroscience while supporting translational healthcare research.

Publications

  • AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders, Cell Biochemistry and Function (2026). DOI: 10.1002/cbf.70270.
  • Prophylactic effects of tranexamic acid in spinal fusion, Egyptian Journal of Neurosurgery (2026). DOI: 10.1186/s41984-026-00560-8.
  • Giant Lumbosacral Meningioma Without Dural Attachment in an Adolescent, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578462.
  • Management of Intrathoracic Huge Meningocele in Neurofibromatosis Type-1, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578419.
  • Kümmell’s Disease in Benign Vertebral Compression Fractures, Clinical Neurology and Neurosurgery (2026). DOI: 10.1016/j.clineuro.2025.109262.

Research Impact

Available bibliometric indicators demonstrate an established publication record comprising 32 indexed documents, 638 citations, and an h-index of 10. These metrics indicate continued scholarly engagement and measurable scientific visibility within biomedical research.[1] The combination of molecular biology, neuroscience, and clinical investigations contributes to interdisciplinary knowledge relevant to both research laboratories and healthcare practice.

Award Suitability

Based on the available academic profile, publication activity, citation performance, interdisciplinary research scope, and contributions to peer-reviewed biomedical literature, Kamran Hosseini demonstrates characteristics commonly evaluated for academic recognition programs such as the Best Researcher Award. His research integrates molecular science with clinical application while contributing to neurological disease research, spinal surgery, and translational medicine through internationally published scientific work.[2]

Conclusion

Kamran Hosseini’s scholarly record reflects sustained participation in biomedical research characterized by interdisciplinary collaboration, clinically relevant investigations, and measurable academic impact. His publication portfolio, citation metrics, and recent contributions to neuroscience and molecular biology illustrate a research trajectory aligned with internationally recognized standards of scientific excellence and make his profile appropriate for consideration within academic recognition initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: Kamran Hosseini, Author ID 57226155096. Scopus.
    https://www.scopus.com/pages/authors/57226155096
  2. ORCID. (n.d.). Kamran Hosseini ORCID Record.
    https://orcid.org/0000-0003-1189-7143
  3. Hosseini K. et al. (2026). AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and Human Studies. Cell Biochemistry and Function. DOI: https://doi.org/10.1002/cbf.70270
  4. Hosseini K. et al. (2026). Prophylactic effects of tranexamic acid in spinal fusion. Egyptian Journal of Neurosurgery. https://doi.org/10.1186/s41984-026-00560-8
  5. Recent peer-reviewed publications in International Medical Case Reports Journal and Clinical Neurology and Neurosurgery (2026). https://doi.org/10.2147/IMCRJ.S578462

Paroma Arefin | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Paroma Arefin
Affiliation University of Houston
Country United States
Scopus ID 57041256700
Documents 15
Citations 67
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0002-5968-1002

Paroma Arefin

Institution: University of Houston, United States

Paroma Arefin is a researcher whose scholarly work spans pharmaceutical sciences, proton exchange membrane fuel cells, hydrogen energy technologies, biomaterials, and public health research. Her interdisciplinary publications demonstrate contributions to pharmaceutical formulation, sustainable energy systems, healthcare technologies, and consumer health awareness. Through peer-reviewed research, she has participated in studies addressing fuel cell durability, drug delivery systems, mobility assistance technologies, and healthcare education, reflecting an interdisciplinary approach that bridges engineering and pharmaceutical sciences.[1]

Abstract

This article summarizes the academic profile and research achievements of Paroma Arefin in recognition of the Women Researcher Award. Her publications primarily address proton exchange membrane fuel cells, hydrogen-powered transportation, pharmaceutical formulation, biomaterials, and healthcare studies. These contributions demonstrate interdisciplinary scholarship that combines pharmaceutical sciences with emerging sustainable energy technologies and applied healthcare research. Her publication record, citation profile, and collaborative research activities illustrate continued participation in internationally visible scientific literature.[1][2]

Keywords

Women Researcher Award, Paroma Arefin, Pharmaceutical Science, Proton Exchange Membrane Fuel Cell, Hydrogen Energy, Drug Delivery, Biomaterials, Fuel Cell Durability, Healthcare Research, University of Houston.

Introduction

Interdisciplinary scientific research increasingly contributes to addressing global healthcare and energy challenges. Paroma Arefin’s scholarly work reflects this trend through publications involving pharmaceutical formulations, hydrogen fuel cell technology, mobility assistance devices, and public health awareness. Her research integrates engineering concepts with pharmaceutical sciences to explore practical solutions that may contribute to healthcare innovation and sustainable energy development.[2]

Research Profile

  • Affiliation: University of Houston.
  • Research specialization includes Pharmacology, Toxicology and Pharmaceutical Science.
  • Scopus Author ID: 57041256700.
  • Research output includes interdisciplinary studies in pharmaceutical sciences, hydrogen fuel cells and healthcare.
  • Publication metrics include 15 indexed documents, 67 citations and an h-index of 6.

Research Contributions

Paroma Arefin has co-authored review articles examining durability factors affecting proton exchange membrane fuel cells, including the influence of operating temperature and membrane degradation mechanisms. These studies provide comprehensive overviews of hydrogen fuel cell technologies and summarize engineering challenges affecting long-term performance.[3]

Her pharmaceutical research includes formulation and characterization of controlled-release microspheres containing Fexofenadine hydrochloride, contributing to studies on drug delivery systems and controlled pharmaceutical release technologies.[4]

Additional publications address consumer awareness regarding food adulteration, mobility assistive devices for elderly populations, and hydrogen-powered transportation systems, demonstrating broad interdisciplinary engagement across engineering and health sciences.[5]

Publications

  • Effect of temperature on the performance factors and durability of proton exchange membrane of hydrogen fuel cell: A narrative review (2020).
  • Proton exchange membrane fuel cell durability factors, challenges, and future perspectives: A detailed review (2021).
  • Study on awareness about food adulteration and consumer rights among consumers in Dhaka, Bangladesh (2020).
  • Adoption of hydrogen fuel cell vehicles and its prospects for the future: A review (2022).
  • Design, characterization and in vitro evaluation of HPMC K100 M CR loaded Fexofenadine HCl microspheres (2016).
  • A comparison of mobility assistive devices for elderly and patients with lower limb injury: Narrative Review.

Research Impact

Citation indicators demonstrate measurable academic visibility within pharmaceutical science and hydrogen energy research. Review articles concerning proton exchange membrane fuel cells have contributed to knowledge synthesis in sustainable energy technologies, while pharmaceutical formulation studies support advances in controlled drug delivery. Collectively, these works reflect interdisciplinary collaboration and continued scholarly engagement across multiple research domains.[1][3]

Award Suitability

Based on her documented publication record, interdisciplinary collaborations, citation profile, and research contributions spanning pharmaceutical sciences, hydrogen fuel cell technologies, healthcare applications, and public health, Paroma Arefin demonstrates characteristics consistent with recognition through the Women Researcher Award. Her research portfolio illustrates continued scholarly activity, international collaboration, and contributions to scientific literature relevant to sustainable technologies and pharmaceutical innovation.[1]

Conclusion

Paroma Arefin’s academic record demonstrates interdisciplinary scholarship across pharmaceutical science, sustainable energy technologies, healthcare engineering, and biomedical research. Her publications, citation metrics, and collaborative research activities collectively represent meaningful contributions to contemporary scientific literature. The combination of pharmaceutical innovation and engineering-focused sustainability research supports her recognition within international academic award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Paroma Arefin, Author ID 57041256700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57041256700
  2. Salam, M. A., Habib, M. S., Arefin, P., Ahmed, K., Uddin, S., Hossain, T., & Papri, N. (2020).
    Effect of Temperature on the Performance Factors and Durability of Proton Exchange Membrane of Hydrogen Fuel Cell: A Narrative Review.
    Material Science Research India, 17(2), 179–191.
    DOI: https://doi.org/10.13005/msri/170207
  3. Habib, M. S., Arefin, P., Salam, M. A., Ahmed, K., Uddin, M. S., Hossain, T., Papri, N., et al. (2021). Proton Exchange Membrane Fuel Cell (PEMFC) Durability Factors, Challenges, and Future Perspectives: A Detailed Review.
    Material Science Research India, 18(2), 217–234.
    DOI: https://doi.org/10.13005/msri/180209
  4. Arefin, P., Hasan, I., & Reza, M. S. (2016).
    Design, Characterization and In Vitro Evaluation of HPMC K100 M CR Loaded Fexofenadine HCl Microspheres.  SpringerPlus, 5, 691. DOI: https://doi.org/10.1186/s40064-016-2322-2
  5. Habib, M. S., & Arefin, P. (2022).
    Adoption of Hydrogen Fuel Cell Vehicles and Its Prospects for the Future (A Review).
    Oriental Journal of Chemistry, 38(3), 621–631. DOI: https://doi.org/10.13005/ojc/380311

Promise Paul | Biochemistry | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Promise Paul
Affiliation Michael Okpara University of Agriculture, Umudike
Country Nigeria
Google Scholar ID o4j7GMIAAAAJ
Documents 6
Citations 24
h-index 1
Subject Area Biochemistry
Event International Academic Achievements & Awards
ORCID 0009-0002-7532-8409

Researcher: Promise Paul
Institution: Michael Okpara University of Agriculture, Umudike

Promise Paul is a researcher affiliated with Michael Okpara University of Agriculture, Umudike, Nigeria, whose scholarly activities are centered on biochemistry, toxicology, environmental health, immunology, and emerging public health technologies. His published research demonstrates interdisciplinary collaboration involving biochemical mechanisms, environmental risk assessment, immunomodulation, and artificial intelligence applications in healthcare. Based on the available scholarly record, his work reflects an emphasis on translating laboratory findings into practical biomedical and public health applications.[1][2]

Abstract

Promise Paul has contributed to a growing body of interdisciplinary research spanning biochemical sciences, environmental toxicology, occupational exposure assessment, immunology, and public health. His publications investigate volatile organic compound interactions with biological receptors, bioaccumulation of toxic elements in aquatic organisms, antioxidant mechanisms, immune regulation, and artificial intelligence applications in disease surveillance. Collectively, these studies contribute to understanding disease prevention, environmental safety, and biomedical innovation while supporting evidence-based public health practices.[2][3]

Keywords

Biochemistry, Environmental Toxicology, Occupational Health, Drug Design, Artificial Intelligence, Public Health, Immunology, Oxidative Stress

Introduction

Modern biomedical research increasingly depends on interdisciplinary collaboration to address complex health and environmental challenges. Promise Paul’s research portfolio reflects this approach by integrating biochemical investigation with environmental science, clinical perspectives, and computational technologies. His collaborative publications examine toxicological mechanisms, disease prevention, environmental monitoring, and innovative analytical strategies that support scientific understanding across multiple disciplines.[2]

Research Profile

The available publication record indicates research interests spanning molecular toxicology, pharmacology, environmental biochemistry, immunomodulation, veterinary science, and digital public health. His collaborative studies frequently investigate biological responses to toxic compounds, mechanisms of oxidative stress, environmental contaminants, and innovative approaches for disease surveillance using artificial intelligence technologies. These areas collectively contribute to improving scientific understanding of health risks and preventive strategies.[1]

Research Contributions

  • Investigated volatile organic compound interactions with drug receptors to support rational drug discovery strategies.
  • Contributed to environmental health studies evaluating toxic element bioaccumulation in commercially important fish species.
  • Participated in immunology research examining therapeutic approaches for congenital immunodeficiencies.
  • Co-authored research exploring ethical implementation of artificial intelligence for public health surveillance.
  • Investigated antioxidant effects of L-Arginine against carbon tetrachloride-induced oxidative damage in experimental animal models.

Publications

  1. Volatile organic compound–drug receptor interactions: a potential tool for drug design in the search for remedies for increasing toxic occupational exposure. Processes, 13(1), 154. DOI: https://doi.org/10.3390/pr13010154
  2. Bioaccumulation and Human Health Risk Assessment of Potentially Toxic Elements in Commercial Fish Species. International Journal of Environmental Research and Public Health, 23(7), 827.
  3. Immunomodulation in Congenital Immunodeficiencies: Targeting Innate and Adaptive Pathways. Clinical Medicine and Integrative Therapies, 1(1), 36–52.
  4. Artificial Intelligence for Public Health Surveillance: Promises, Pitfalls, and an Ethics-Equity Roadmap for Deployment. Disease Prevention and Epidemiology, 1(1), 22–39.
  5. Antioxidant Effects of L-Arginine on Redox Profile of Carbon Tetrachloride (CCl4)-Intoxicated Albino Rats. Journal of Sustainable Veterinary & Allied Sciences, 7(4), 385–391.

Research Impact

Although currently representing an early-stage publication profile, the available scholarly metrics indicate growing visibility through peer-reviewed publications and citations. The interdisciplinary nature of these investigations contributes to knowledge spanning environmental safety, biomedical science, toxicology, and digital health while encouraging collaboration across multiple scientific disciplines.[2]

Award Suitability

Promise Paul’s research portfolio demonstrates characteristics commonly considered for emerging research recognition, including interdisciplinary collaboration, publication in peer-reviewed journals, investigation of contemporary biomedical and environmental issues, and contributions to public health research. The Innovative Research Award appropriately recognizes researchers developing multidisciplinary scientific approaches with potential societal relevance.[1][2]

Conclusion

Promise Paul has established an emerging interdisciplinary research profile focused on biochemistry, environmental health, immunology, toxicology, and artificial intelligence applications in medicine. His collaborative publications demonstrate scientific engagement with important biomedical and environmental challenges, supporting continued academic development and making his work consistent with the objectives of recognizing innovative scientific research.

References

  1. Google Scholar. (n.d.). Promise Paul – Google Scholar Citations Profile.
    https://scholar.google.com/citations?user=o4j7GMIAAAAJ&hl=en&oi=ao
  2. Processes. (2025). Volatile organic compound–drug receptor interactions: a potential tool for drug design in the search for remedies for increasing toxic occupational exposure.DOI:https://doi.org/10.3390/pr13010154
  3. ORCID. (n.d.). Promise Paul ORCID Record.
    https://orcid.org/0009-0002-7532-8409
  4. Crossref DOI Foundation. (n.d.). DOI Metadata and Scholarly Record Services.

Shaghayegh Mirhosseini | Bio Engineering | Best Researcher Award

Published on by Academic Achievements

Ms. Shaghayegh Mirhosseini | Bio Engineering | Best Researcher Award 

Ph.D. student at University of Virginia, United States

Shaghayegh Mirhosseini is an emerging researcher specializing in bioelectronics, cancer diagnostics, and microfluidics. She has extensive experience in the interdisciplinary field of bio-MEMS (microelectromechanical systems) and has made significant contributions to the study of cancer cells in microfluidic environments. With ongoing Ph.D. research in two prestigious universities, Mirhosseini’s work bridges the gap between biological science and electrical engineering, creating innovative solutions for cancer detection and treatment through advanced microfluidic technologies.

Profile

GOOGLE SCHOLAR

Education

Shaghayegh is currently pursuing two Ph.D. degrees, one from the University of Virginia, where her focus is on cancer cells in microfluidic devices under the supervision of Prof. Nathan Swami, and another from the University of Tehran, where her research centers around separating Circulating Tumor Cells (CTCs) using deterministic lateral displacement (DLD) microfluidic systems. She holds a Master’s degree in Electrical Engineering with a focus on bioelectronics from the University of Tehran, where she worked on the simulation and fabrication of Erbium-doped waveguide amplifiers. Shaghayegh’s academic journey began with a Bachelor’s degree in Electrical Engineering from the University of Kashan, where she designed digital password locks using AVR microcontrollers.

Research Experience

Her diverse research experience spans multiple countries and institutions. At the University of Tehran, she was actively involved in the MEMS & NEMS Laboratory and the Urology Research Center. She further broadened her research scope as a visiting researcher at the University of Virginia and Mälardalen University in Sweden. Her work on bioelectronics, microfluidics, and cancer research has led to numerous publications in prestigious journals. Notably, her contributions to the separation and analysis of circulating tumor cells (CTCs) are innovative, offering potential for groundbreaking cancer diagnostics.

Research Interests

Shaghayegh’s research interests lie at the intersection of biology and electronics. She is particularly focused on cancer research, microfabrication, microfluidic device design, and MEMS technologies. Her expertise in microfluidics and bio-MEMS allows her to explore new diagnostic technologies, especially for cancer detection. She is also interested in machine learning and image processing, which she integrates into her research to develop more efficient and automated cancer cell detection systems. Additionally, Shaghayegh is passionate about drug delivery systems, colorimetric analysis, and the synthesis of gold nanoparticles, which play vital roles in her research projects.

Awards and Recognition

Although Shaghayegh Mirhosseini is still completing her doctoral studies, her innovative research contributions have already garnered significant recognition in the academic community. Her international collaborations and published works have earned her respect from her peers, leading to opportunities for collaboration with top researchers in the field of bioelectronics and cancer diagnostics. While specific awards are yet to be disclosed, her research publications and contributions to cancer diagnostics are paving the way for future accolades.

Publications

  1. Signal-Based Methods in Dielectrophoresis for Cell and Particle Separation
    Published in 2022, cited by multiple articles. Read the full article.
  2. Microstructured Droplet-Based Porous Capacitive Pressure Sensor
    Published in 2021, cited by multiple articles. Read the full article.
  3. Fabrication of an erbium–ytterbium-doped waveguide amplifier at communication wavelengths for integrated optics applications
    Published in 2020, cited by multiple articles. Read the full article.
  4. A digital image colorimetry system based on smart devices for enzyme-linked immunosorbent assays
    Published in 2020, cited by multiple articles. Read the full article.
  5. Effective boundary correction for deterministic lateral displacement microchannels to improve cell separation
    Published in 2023, cited by multiple articles. Read the full article.
  6. Neural network-enabled multiparametric impedance signal templating for high throughput single-cell deformability cytometry
    Published in 2023, cited by multiple articles. Read the full article.

Conclusion

Shaghayegh Mirhosseini presents a strong candidate for the Best Researcher Award due to her significant contributions in bioelectronics and cancer research. Her interdisciplinary expertise, combined with international research exposure, strong publication record, and technical mastery, makes her a highly deserving researcher. With ongoing improvements, including the completion of her Ph.D. studies and a stronger focus in a specialized niche, her potential to make transformative contributions to science is immense.

 

Mohammad Ali Takhshid | Biotechnology | Best Researcher Award

Published on by Academic Achievements

Prof. Dr. Mohammad Ali Takhshid | Biotechnology | Best Researcher Award 

Professor of clinical Biochemistry | Shiraz university of Medical Sciences | Germany

Dr. Mohammad Ali Takhshid is a distinguished Professor of Clinical Biochemistry at the Faculty of Paramedical Sciences, Shiraz University of Medical Sciences, Iran. With over two decades of experience in the field, he is known for his significant contributions to clinical biochemistry, particularly in cancer research, diabetes, and oxidative stress. Dr. Takhshid’s work is recognized for its innovative approaches and extensive publication record, reflecting his dedication to advancing scientific knowledge and improving health outcomes.

Profile

ORCID

Strengths

  1. Extensive Research Output: Dr. Takhshid has a substantial number of publications across various high-impact journals. His work covers a range of topics, including clinical biochemistry, cancer research, diabetes, oxidative stress, and genetic studies. This breadth of research demonstrates a strong command of his field and a versatile approach to scientific inquiry.
  2. Recent and Relevant Contributions: His recent publications are in reputable journals and address current and relevant issues in clinical biochemistry and related fields. For instance, studies on biomarkers for diabetes complications and the role of oxidative stress in various conditions are highly relevant.
  3. Diverse Research Topics: Dr. Takhshid’s research spans several important areas within clinical biochemistry, such as the role of biomarkers in disease diagnosis and the impact of various compounds on cellular health. This diversity indicates a broad expertise and the ability to address complex scientific problems from multiple angles.
  4. Innovative Research Approaches: His work includes advanced methodologies like CRISPR/Cas9 gene editing, targeted overexpression studies, and the investigation of oxidative stress mechanisms. Such innovative approaches highlight his commitment to cutting-edge science and technology.
  5. Collaborative Efforts: Dr. Takhshid’s publications often involve collaborations with other researchers, which can enhance the quality and impact of his work. Collaboration suggests a willingness to engage with the broader scientific community and integrate diverse perspectives into his research.

Areas for Improvement

  1. Impact Factor of Journals: While Dr. Takhshid has published in numerous journals, some may not have the highest impact factors. Publishing in higher-impact journals could further elevate the visibility and influence of his research.
  2. Interdisciplinary Research: Expanding the focus of his research to include interdisciplinary approaches could offer new insights and enhance the applicability of his findings. Integrating knowledge from related fields, such as computational biology or systems biology, might lead to novel discoveries.
  3. Research Funding and Grants: The CV does not mention research funding or grants. Securing competitive grants could support more extensive research projects and enhance the overall impact of his work. Information about funded projects could also strengthen his case for the award.
  4. Public Engagement and Outreach: Increasing involvement in public science communication and outreach activities could help in translating his research to broader audiences. Engaging with the public or policymakers could amplify the societal impact of his work.
  5. Citations and Research Impact: While the volume of publications is significant, assessing the citation impact of his work would provide a clearer picture of its influence on the field. Tracking citations and the influence of his research on subsequent studies could highlight his contributions more effectively.

Education

Dr. Takhshid earned his Bachelor of Science in Biological Sciences from Shiraz University in 1990. He continued his education at Isfahan University of Medical Sciences, where he completed his Master of Science in Clinical Biochemistry in 1995. He further pursued his doctoral studies at Shiraz University of Medical Sciences, obtaining a Ph.D. in Clinical Biochemistry in 2003. His academic journey reflects a solid foundation and expertise in his field.

Experience

Dr. Takhshid began his academic career as a Lecturer in Biochemistry at Fasa University of Medical Sciences from 2003 to 2006. Since 2007, he has been a Lecturer and then Professor in Clinical Biochemistry at the Department of Medical Laboratory Sciences, Faculty of Paramedical Sciences, Shiraz University of Medical Sciences. His long-standing role at Shiraz University underscores his commitment to education and research in clinical biochemistry.

Research Interests

Dr. Takhshid’s research interests encompass various aspects of clinical biochemistry, including the molecular mechanisms of cancer, diabetes-related complications, oxidative stress, and genetic factors influencing disease processes. His work often involves innovative methodologies such as gene editing and biomarker analysis, aiming to enhance diagnostic and therapeutic strategies in medical science.

Awards

While specific awards are not listed in the provided CV, Dr. Takhshid’s extensive research contributions and high-quality publications are indicative of his recognition within the scientific community. His achievements in research and academia suggest a strong potential for receiving prestigious awards in his field.

Publications

Here is a selection of Dr. Takhshid’s recent publications with hyperlinks:

Targeted Overexpression of NDRG2 using Survivin Promoter Reduces Viability and Invasiveness of A549 Cell Line
Avicenna Journal of Medical Biotechnology, 2023
Link

Combined Effects of Sodium Valproate and Lithium Chloride on Inducing Apoptosis and Inhibiting Invasion of PC3 Cells
Middle East Journal of Cancer, 2023
Link

Diagnostic Values of Ischemia Modified Albumin in Diabetes-Related Complications: A Narrative Review
Journal of Diabetes & Metabolic Disorders, 2022
Link

Expression of DDB2, XPC, and GADD45 Genes after Whole Body Gamma Irradiation
Iranian Journal of Medical Physics, 2022
Link

A Review of Laboratory Methods for Measuring Oxidative Stress
Journal of Shahid Sadoughi University of Medical Sciences, 2022
Link

Serum Biomarkers for Assessing Glycemic Control in Diabetes Mellitus
Laboratory & Diagnosis, 2022
Link

Diverse Effect of Vitamin C and N-Acetylcysteine on Aluminum-Induced Eryptosis
Biochem Res Int, 2021
Link

Association of Vitamin D Deficiency with Vitamin D Binding Protein (DBP) and CYP2R1 Polymorphisms in Iranian Population
Meta Gene, 2021
Link

Adrenomedullin Increases cAMP Accumulation and BDNF Expression in Rat DRG and Spinal Motor Neurons
Iranian Journal of Basic Medical Sciences, 2021
Link

Association of Serum Kynurenine/Tryptophan Ratio with Poor Glycemic Control in Patients with Type 2 Diabetes
J Diabetes Metab Disord, 2021
Link

Conclusion

Dr. Mohammad Ali Takhshid is a strong candidate for the Best Researcher Award. His extensive publication record, innovative research methods, and diverse scientific contributions reflect his excellence in the field of clinical biochemistry. To further strengthen his candidacy, addressing areas such as publishing in higher-impact journals, pursuing interdisciplinary research, and increasing public engagement could enhance his profile. Overall, his significant contributions and active research output make him a commendable nominee for the award.

 

Morteza Hosseini – Environmental Biotechnology – Best Faculty Award

Published on by Academic Achievements

Morteza Hosseini - Environmental Biotechnology - Best Faculty Award

Babol Noshirvani University of Technology - Iran

Early Academic Pursuits

Morteza Hosseini's academic odyssey commenced with a solid foundation in Chemical Engineering at the Faculty of Engineering, Tech. University of Graz, Austria. His academic journey, spanning from B.Sc. to Ph.D., showcased a commitment to environmental biotechnology, culminating in a dissertation on the biological cleansing of waste air. The early years of education laid the groundwork for his future contributions to the field.

Professional Endeavors

Joining Babol Noshirvani University of Technology in Iran in September 2000 marked a significant chapter in Hosseini's professional life. As an Associate Professor, he brought his expertise to the forefront, contributing to both academia and research. Prior to his tenure at Babol Noshirvani University, Hosseini engaged in impactful projects at the Institute of Environmental Biotechnology, Tech. University of Graz, Austria, from 1998 to 2000, focusing on biological treatment of wastewater and air pollution. As a leader in the discipline, he champions eco-friendly solutions, environmental stewardship, and the development of cutting-edge biotechnological strategies to safeguard and improve the health of our planet

Contributions and Research Focus

Hosseini's research journey reflects a diverse array of interests. From his early work on wastewater treatment using non-uniform electrical fields to his later investigations into the desalination of crude oil, his contributions underscore a multidisciplinary approach to solving complex environmental challenges. His expertise extends to the coagulation of colloidal particles and the electrostatic enhancement of coalescence in emulsions. Morteza Hosseini, an expert in this field, pioneers research and advancements in Environmental Biotechnology, earning recognition for his contributions. His work contributes to sustainable practices, earning accolades and the Best Faculty Award.

Accolades and Recognition

Throughout his career, Morteza Hosseini has earned recognition for his impactful contributions to the field of Chemical Engineering. His notable publications, including works on the elimination of CO and NO in bio reactors, have garnered attention in academic circles. Notably, his leadership role as the Head of Biotechnology Faculty at Babol Noshirvani University of Technology from 2019 to 2021 further highlights his recognition as a trusted figure in the academic community.

Impact and Influence

Hosseini's influence extends beyond the confines of his academic roles. His leadership positions, both as the Head of Biotechnology Faculty and as a Project Leader in Austria, demonstrate his capacity to guide and direct research endeavors. Moreover, his engagement with various professional societies, such as the Iranian Society of Chemical Engineers and the Iranian Nanotechnology Society, reflects a commitment to broader community impact. Environmental Biotechnology involves the application of biological processes to solve environmental challenges. Through innovative techniques like bioremediation and sustainable technologies, it addresses issues such as pollution, waste treatment, and ecological restoration.

Legacy and Future Contributions

As a seasoned educator, Hosseini has left an indelible mark on the academic landscape, having taught a range of courses and supervised numerous undergraduate and postgraduate projects. His legacy includes a significant contribution to the development of the Chemical Engineering Department at Mazandaran University, where he served as the Head from 2001 to 2003. Looking ahead, Morteza Hosseini's future contributions are poised to further enrich the realms of environmental biotechnology and chemical engineering. His research pursuits, particularly in the application of electrical fields for wastewater treatment and emulsion preparation, indicate a continued dedication to innovative solutions for pressing environmental challenges.

Notable Publications

Design of PAMAM grafted chitosan dendrimers biosorbent for removal of anionic dyes: Adsorption isotherms, kinetics and thermodynamics studies 2021 (60)

Fabrication and characterization of polyvinyl chloride mixed matrix membranes containing high aspect ratio anatase titania and hydrous manganese oxide nanoparticle for efficient removal of heavy metal ions: Competitive removal study 2020 (18)

Extraction of Catechin as a Flavonoid Compound via Molecularly Imprinted Polymers 2022 (7)